The Missouri House gave initial approval to a proposal that would legalize cannabis for medical use. If finalized, patients suffering from long-term and terminal diseases like cancer, Parkinson’s, epilepsy, and PTSD would be able to use the drug.
The bill was approved on a voice vote and needs a final vote to move to the Senate. This bill allows anyone 18 years or above with a terminal disease to access smokeless CBD products.
CBD and medical cannabis products are therapeutic and play a significant role in treating certain medical conditions. Besides this, these products are non-psychoactive and non-addictive in nature.
The House Bill 1554 was originally proposed for terminally ill patients. The bill intends to help patients who are on the verge of dying. A member of the House, Representative Shamed Dogan (R-Ballwin), proposed an amendment to the bill. He advised they should include non-terminal illnesses like Alzheimer’s and multiple sclerosis as qualifying conditions for CBD use.
The House debated on the proposed amendment and decided to add the additional medical conditions to the list of qualifying conditions. The initial bill proposed to the Senate received testification from veterans and their families. However, the bill has been changed to give more patients access to CBD.
Earlier this year, the Missouri Association of Prosecuting Attorneys testified against the bill by calling CBD illegal under federal law. In 2016, the house debated a similar bill but the representatives voted it down.
The market for medical cannabis and its extracted components is growing profusely. The medicinal properties of cannabidiol have helped the compound penetrate various industries like beverage, food, lifestyle, and cosmetics. According to Forbes, the industry is speculated to grow 700% to touch $2.1 billion by 2020. The industry accounted for $202 million last year.